Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/28/25 → 3/28/28 |
Funding
- Replimune, Inc. (Prot #RP2-202)
Prot #RP2-202: A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combination with Nivolumab versus Ipilimumab in Combination with Nivolumab in Immune Checkpoint InhibitorNaïve Adult Patients with Metastatic Uveal M
- Chandra, Sunandana (PD/PI)
Project: Research project